Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #247030 on Biotech Values
Whalatane
05/17/23 5:29 PM
#247035 RE: rfj1862 #247030
Conclusion: This interim analysis suggests that narsoplimab treatment is safe, is well tolerated, and may result in clinically meaningful reductions in proteinuria and stability of eGFR in high-risk patients with advanced IgAN